T+R AG Competitors

Henry Schein, Inc. (Nasdaq: HSIC) is a products, services, and technology platforms company for healthcare customers. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional healthcare clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers. A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 34 countries and territories. The Company's sales reached $13.2 billion in 2025, and have grown at a compound annual rate of approximately 11.0 percent since Henry Schein became a public company in 1995.

The KLS Martin Group is an international company group for innovative medical technology in almost all surgical areas. With our philosophy "Surgical Innovation is our Passion", we develop and market solutions such as implant systems, electrosurgery units, surgical laser systems, operating lights, surgical instruments, and tray systems. Whatever you need – we're just around the corner.

Nobel Biocare is a world leader in the field of innovative implant-based dental restorations – from single-tooth to fully edentulous indications. The company’s portfolio offers: - Dental implant systems - Individualized prosthetics and CAD/CAM systems - Treatment planning - Guided surgery solutions - Biomaterials Our goal is to empower dental professionals to give quality of life back to their patients. This philosophy is built on over 60 years of continuous innovation, all stemming from Per-Ingvar Brånemark’s ground-breaking discovery of osseointegration in 1952. Since then, we’ve helped our customers treat millions of patients. Privacy policy: http://bit.ly/2T1atvE Disclaimer: We welcome and encourage your comments and look forward to engaging with you. While you're here, we request that you follow a few basic guidelines: - If you wish to report product complaints, side effects or adverse events to us or have Customer Support related questions or inquiries, please contact Post Market Surveillance (PMS) team at productcomplaint@nobelbiocare.com.. Nobel Biocare will follow its normal process in referring any such reports to the appropriate department and, therefore, reserves the right to remove any such complaints or reports from this site. - To ensure that our page provides meaningful interactions, please keep comments on topic whenever possible. - Postings that are considered abusive, or that infringe copyright or intellectual property rights of others will be removed at our discretion. - We reserve the right to remove a topic or comment at our discretion. - The collection, storage, use, disclosure, retention and destruction of data on this page, including any personal data, are all subject as applicable, to Nobel Biocare’s Terms of Use and Privacy Policy.